By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Current study results on DNA Research have been published. According to news reporting originating from Philadelphia, Pennsylvania, by NewsRx editors, the research stated, "Science is host to a constantly emerging series of new paradigms, and it is this characteristic that makes science both interesting and dynamic. As a part of this continuum, it became possible to create recombinant DNA molecules."
Our news editors obtained a quote from the research from the University of Pennsylvania, "Immediately it was recognized that there was a potential for serious adverse events associated with this new technology. Following two scientific conferences at Asilomar, California, the National Institutes of Health moved quickly to create the Recombinant DNA Advisory Committee (RAC). For approximately 38 years the RAC has served as an open forum for review of various recombinant DNA experiments, and for the last 23 years it has played a pivotal role in the oversight of human gene therapy."
According to the news editors, the research concluded: "The RAC's existence obviated the need for more restrictive governmental legislation and has supported the development of genetic interventions that are leading to actual human therapies."
For more information on this research see: Historical Perspectives Pertaining to the NIH Recombinant DNA Advisory Committee. Human Gene Therapy, 2014;25(1):19-24. Human Gene Therapy can be contacted at: Mary Ann Liebert, Inc, 140 Huguenot Street, 3RD Fl, New Rochelle, NY 10801, USA. (Mary Ann Liebert, Inc. - www.liebertpub.com; Human Gene Therapy - www.liebertpub.com/overview/human-gene-therapy-and-part-b-methods/19/)
The news editors report that additional information may be obtained by contacting N.A. Wivel, University of Pennsylvania, Sch Med, Inst Human Gene Therapy, Philadelphia, PA 19104, United States (see also DNA Research).
Keywords for this news article include: Biotechnology, Philadelphia, Pennsylvania, DNA Research, Gene Therapy, United States, Bioengineering, Adverse Drug Reaction, North and Central America, Government Agencies Offices and Entities
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC